KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Total Debt (2018 - 2025)

Twist Bioscience (TWST) has disclosed Total Debt for 6 consecutive years, with $15.0 million as the latest value for Q4 2025.

  • Quarterly Total Debt changed 0.0% to $15.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $15.0 million through Dec 2025, changed 0.0% year-over-year, with the annual reading at $15.0 million for FY2025, N/A changed from the prior year.
  • Total Debt for Q4 2025 was $15.0 million at Twist Bioscience, roughly flat from $15.0 million in the prior quarter.
  • The five-year high for Total Debt was $15.0 million in Q4 2024, with the low at $1.6 million in Q3 2021.
  • Average Total Debt over 3 years is $10.1 million, with a median of $15.0 million recorded in 2024.
  • Peak annual rise in Total Debt hit 129.46% in 2021, while the deepest fall reached 67.23% in 2021.
  • Over 3 years, Total Debt stood at $9.1 million in 2021, then skyrocketed by 65.16% to $15.0 million in 2024, then changed by 0.0% to $15.0 million in 2025.
  • According to Business Quant data, Total Debt over the past three periods came in at $15.0 million, $15.0 million, and $15.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.